Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials
Open Access
- 15 January 2017
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (12), 20410-20417
- https://doi.org/10.18632/oncotarget.14669
Abstract
Background: The long-term survival benefit of concurrent neoadjuvant chemoradiotherapy in patients with resectable esophageal cancer remains controversial. In the present study, we conducted a meta-analysis to assess these effectiveness.Keywords
This publication has 26 references indexed in Scilit:
- Neoadjuvant Chemoradiotherapy Could Improve Survival Outcomes for Esophageal Carcinoma: A Meta-AnalysisDigestive Diseases and Sciences, 2012
- Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinomaWorld Journal of Gastroenterology, 2010
- Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinomaDiseases of the Esophagus, 2009
- Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781Journal of Clinical Oncology, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institutionDiseases of the Esophagus, 2006
- A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinomaAnnals of Oncology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Aggregate data meta‐analysis with time‐to‐event outcomesStatistics in Medicine, 2002